RB Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,478
Closed -$222K 124
2018
Q3
$222K Sell
2,478
-200
-7% -$17.7K 0.2% 106
2018
Q2
$213K Buy
2,678
+200
+8% +$16.6K 0.16% 124
2018
Q1
$221K Buy
2,478
+138
+6% +$13.2K 0.17% 117
2017
Q4
$244K Buy
2,340
+753
+47% +$85K 0.17% 107
2017
Q3
$231 Buy
1,587
+35
+2% +$4.77K ﹤0.01% 107
2017
Q2
$202K Buy
+1,552
New +$190K 0.17% 110
2017
Q1
Sell
-1,960
Closed -$227K 116
2016
Q4
$227K Buy
+1,960
New +$218K 0.23% 96

Other funds holding CELG

RB Capital Management's CELG Position: Q4 2018 in Review

RB Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,478 shares — an estimated $222K sold.

RB Capital Management first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $244K in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • RB Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • RB Capital Management sold 2,478 Celgene Corp shares in Q4 2018, an estimated $222K.
  • RB Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • RB Capital Management's Celgene Corp position peaked at $244K in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on RB Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.